Malcolm Ward
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Malcolm Ward has a total of 405 co-authors. Here are the top co-authors by number of shared publications:
- Simon Lovestone
Department of Psychiatry, University of Oxford
15 shared publications Helen L. Byers
Proteome Sciences plc, South Wing Laboratory, Institute of Psychiatry, London, UK
10 shared publicationsIan Pike
Proteome Sciences plc, Institute of Psychiatry, Kings College London, South Wing Laboratories, De Crespigny Park, London, SE5 8AF, UK
10 shared publications- Abdul Hye
King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK
9 shared publications - Steven Lynham
Smart Trials Hub, King’s College London, London, UK
9 shared publications - James Campbell
Proteome Sciences plc, London, United Kingdom
7 shared publications
Latest Publications
- Open Access
- 10 June 2021
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 9 (6) , e002140
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
Background Cancer immunotherapy with monoclonal antibodies and chimeric antigen receptor (CAR) T cell therapies can benefit from selection of new targets with high levels of tumor specificity and from early assessments of efficacy and safety to derisk potential therapies. Methods Employing mass spectrometry, bioinformatics, immuno-mass spectrometry and CRISPR/Cas9 we identified the target of the tumor-specific SF-25 antibody. We engineered IgE and CAR T cell immunotherapies derived from the SF-25 clone and evaluated potential for cancer therapy. Results We identified the target of the SF-25 clone as the tumor-associated antigen SLC3A2, a cell surface protein with key roles in cancer metabolism. We generated IgE monoclonal antibody, and CAR T cell immunotherapies each recognizing SLC3A2. In concordance with preclinical and, more recently, clinical findings with the first-in-class IgE antibody MOv18 (recognizing the tumor-associated antigen Folate Receptor alpha), SF-25 IgE potentiated Fc-mediated effector functions against cancer cells in vitro and restricted human tumor xenograft growth in mice engrafted with human effector cells. The antibody did not trigger basophil activation in cancer patient blood ex vivo, suggesting failure to induce type I hypersensitivity, and supporting safe therapeutic administration. SLC3A2-specific CAR T cells demonstrated cytotoxicity against tumor cells, stimulated interferon-γ and interleukin-2 production in vitro. In vivo SLC3A2-specific CAR T cells significantly increased overall survival and reduced growth of subcutaneous PC3-LN3-luciferase xenografts. No weight loss, manifestations of cytokine release syndrome or graft-versus-host disease, were detected. Conclusions These findings identify efficacious and potentially safe tumor-targeting of SLC3A2 with novel immune-activating antibody and genetically modified cell therapies.
- 10 June 2021
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 9 (6) , e002140
Open AccessImmunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2
Background Cancer immunotherapy with monoclonal antibodies and chimeric antigen receptor (CAR) T cell therapies can benefit from selection of new targets with high levels of tumor specificity and from early assessments of efficacy and safety to derisk potential therapies. Methods Employing mass spectrometry, bioinformatics, immuno-mass spectrometry and CRISPR/Cas9 we identified the target of the tumor-specific SF-25 antibody. We engineered IgE and CAR T cell immunotherapies derived from the SF-25 clone and evaluated potential for cancer therapy. Results We identified the target of the SF-25 clone as the tumor-associated antigen SLC3A2, a cell surface protein with key roles in cancer metabolism. We generated IgE monoclonal antibody, and CAR T cell immunotherapies each recognizing SLC3A2. In concordance with preclinical and, more recently, clinical findings with the first-in-class IgE antibody MOv18 (recognizing the tumor-associated antigen Folate Receptor alpha), SF-25 IgE potentiated Fc-mediated effector functions against cancer cells in vitro and restricted human tumor xenograft growth in mice engrafted with human effector cells. The antibody did not trigger basophil activation in cancer patient blood ex vivo, suggesting failure to induce type I hypersensitivity, and supporting safe therapeutic administration. SLC3A2-specific CAR T cells demonstrated cytotoxicity against tumor cells, stimulated interferon-γ and interleukin-2 production in vitro. In vivo SLC3A2-specific CAR T cells significantly increased overall survival and reduced growth of subcutaneous PC3-LN3-luciferase xenografts. No weight loss, manifestations of cytokine release syndrome or graft-versus-host disease, were detected. Conclusions These findings identify efficacious and potentially safe tumor-targeting of SLC3A2 with novel immune-activating antibody and genetically modified cell therapies.
- Open Access
Recruitment of toxin-like proteins with ancestral venom function supports endoparasitic lifestyles of Myxozoa
Cnidarians are the oldest lineage of venomous animals and use nematocysts to discharge toxins. Whether venom toxins have been recruited to support parasitic lifestyles in the Endocnidozoa (Myxozoa + Polypodium) is, however, unknown. To examine this issue we variously employed transcriptomic, proteomic, associated molecular phylogenies, and localisation studies on representative primitive and derived myxozoans (Malacosporea and Myxosporea, respectively), Polypodium hydriforme, and the free-living staurozoan Calvadosia cruxmelitensis. Our transcriptomics and proteomics analyses provide evidence for expression and translation of venom toxin homologs in myxozoans. Phylogenetic placement of Kunitz type serine protease inhibitors and phospholipase A2 enzymes reveals modification of toxins inherited from ancestral free-living cnidarian toxins, and that venom diversity is reduced in myxozoans concordant with their reduced genome sizes. Various phylogenetic analyses of the Kunitz-type toxin family in Endocnidozoa suggested lineage-specific gene duplications, which offers a possible mechanism for enhancing toxin diversification. Toxin localisation in the malacosporean Buddenbrockia plumatellae substantiates toxin translation and thus illustrates a repurposing of toxin function for endoparasite development and interactions with hosts, rather than for prey capture or defence. Whether myxozoan venom candidates are expressed in transmission stages (e.g. in nematocysts or secretory vesicles) requires further investigation.
Open AccessRecruitment of toxin-like proteins with ancestral venom function supports endoparasitic lifestyles of Myxozoa
Cnidarians are the oldest lineage of venomous animals and use nematocysts to discharge toxins. Whether venom toxins have been recruited to support parasitic lifestyles in the Endocnidozoa (Myxozoa + Polypodium) is, however, unknown. To examine this issue we variously employed transcriptomic, proteomic, associated molecular phylogenies, and localisation studies on representative primitive and derived myxozoans (Malacosporea and Myxosporea, respectively), Polypodium hydriforme, and the free-living staurozoan Calvadosia cruxmelitensis. Our transcriptomics and proteomics analyses provide evidence for expression and translation of venom toxin homologs in myxozoans. Phylogenetic placement of Kunitz type serine protease inhibitors and phospholipase A2 enzymes reveals modification of toxins inherited from ancestral free-living cnidarian toxins, and that venom diversity is reduced in myxozoans concordant with their reduced genome sizes. Various phylogenetic analyses of the Kunitz-type toxin family in Endocnidozoa suggested lineage-specific gene duplications, which offers a possible mechanism for enhancing toxin diversification. Toxin localisation in the malacosporean Buddenbrockia plumatellae substantiates toxin translation and thus illustrates a repurposing of toxin function for endoparasite development and interactions with hosts, rather than for prey capture or defence. Whether myxozoan venom candidates are expressed in transmission stages (e.g. in nematocysts or secretory vesicles) requires further investigation.
- Open Access
- 1 April 2017
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 37, 65-71
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
- 1 April 2017
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 37, 65-71
Open AccessIdentification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
- Open Access
- 9 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39328
Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide
The impairment of liver function by low environmentally relevant doses of glyphosate-based herbicides (GBH) is still a debatable and unresolved matter. Previously we have shown that rats administered for 2 years with 0.1 ppb (50 ng/L glyphosate equivalent dilution; 4 ng/kg body weight/day daily intake) of a Roundup GBH formulation showed signs of enhanced liver injury as indicated by anatomorphological, blood/urine biochemical changes and transcriptome profiling. Here we present a multiomic study combining metabolome and proteome liver analyses to obtain further insight into the Roundup-induced pathology. Proteins significantly disturbed (214 out of 1906 detected, q < 0.05) were involved in organonitrogen metabolism and fatty acid β-oxidation. Proteome disturbances reflected peroxisomal proliferation, steatosis and necrosis. The metabolome analysis (55 metabolites altered out of 673 detected, p < 0.05) confirmed lipotoxic conditions and oxidative stress by showing an activation of glutathione and ascorbate free radical scavenger systems. Additionally, we found metabolite alterations associated with hallmarks of hepatotoxicity such as γ-glutamyl dipeptides, acylcarnitines, and proline derivatives. Overall, metabolome and proteome disturbances showed a substantial overlap with biomarkers of non-alcoholic fatty liver disease and its progression to steatohepatosis and thus confirm liver functional dysfunction resulting from chronic ultra-low dose GBH exposure.
- 9 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39328
Open AccessMultiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide
The impairment of liver function by low environmentally relevant doses of glyphosate-based herbicides (GBH) is still a debatable and unresolved matter. Previously we have shown that rats administered for 2 years with 0.1 ppb (50 ng/L glyphosate equivalent dilution; 4 ng/kg body weight/day daily intake) of a Roundup GBH formulation showed signs of enhanced liver injury as indicated by anatomorphological, blood/urine biochemical changes and transcriptome profiling. Here we present a multiomic study combining metabolome and proteome liver analyses to obtain further insight into the Roundup-induced pathology. Proteins significantly disturbed (214 out of 1906 detected, q < 0.05) were involved in organonitrogen metabolism and fatty acid β-oxidation. Proteome disturbances reflected peroxisomal proliferation, steatosis and necrosis. The metabolome analysis (55 metabolites altered out of 673 detected, p < 0.05) confirmed lipotoxic conditions and oxidative stress by showing an activation of glutathione and ascorbate free radical scavenger systems. Additionally, we found metabolite alterations associated with hallmarks of hepatotoxicity such as γ-glutamyl dipeptides, acylcarnitines, and proline derivatives. Overall, metabolome and proteome disturbances showed a substantial overlap with biomarkers of non-alcoholic fatty liver disease and its progression to steatohepatosis and thus confirm liver functional dysfunction resulting from chronic ultra-low dose GBH exposure.
- Open Access
- 19 December 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 37855
An integrated multi-omics analysis of the NK603 Roundup-tolerant GM maize reveals metabolism disturbances caused by the transformation process
Glyphosate tolerant genetically modified (GM) maize NK603 was assessed as ‘substantially equivalent’ to its isogenic counterpart by a nutrient composition analysis in order to be granted market approval. We have applied contemporary in depth molecular profiling methods of NK603 maize kernels (sprayed or unsprayed with Roundup) and the isogenic corn to reassess its substantial equivalence status. Proteome profiles of the maize kernels revealed alterations in the levels of enzymes of glycolysis and TCA cycle pathways, which were reflective of an imbalance in energy metabolism. Changes in proteins and metabolites of glutathione metabolism were indicative of increased oxidative stress. The most pronounced metabolome differences between NK603 and its isogenic counterpart consisted of an increase in polyamines including N-acetyl-cadaverine (2.9-fold), N-acetylputrescine (1.8-fold), putrescine (2.7-fold) and cadaverine (28-fold), which depending on context can be either protective or a cause of toxicity. Our molecular profiling results show that NK603 and its isogenic control are not substantially equivalent.
- 19 December 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 37855
Open AccessAn integrated multi-omics analysis of the NK603 Roundup-tolerant GM maize reveals metabolism disturbances caused by the transformation process
Glyphosate tolerant genetically modified (GM) maize NK603 was assessed as ‘substantially equivalent’ to its isogenic counterpart by a nutrient composition analysis in order to be granted market approval. We have applied contemporary in depth molecular profiling methods of NK603 maize kernels (sprayed or unsprayed with Roundup) and the isogenic corn to reassess its substantial equivalence status. Proteome profiles of the maize kernels revealed alterations in the levels of enzymes of glycolysis and TCA cycle pathways, which were reflective of an imbalance in energy metabolism. Changes in proteins and metabolites of glutathione metabolism were indicative of increased oxidative stress. The most pronounced metabolome differences between NK603 and its isogenic counterpart consisted of an increase in polyamines including N-acetyl-cadaverine (2.9-fold), N-acetylputrescine (1.8-fold), putrescine (2.7-fold) and cadaverine (28-fold), which depending on context can be either protective or a cause of toxicity. Our molecular profiling results show that NK603 and its isogenic control are not substantially equivalent.
- 16 December 2016
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 65 (12) , 1429-1433
Comparative analysis of phenol-soluble modulin production and Galleria mellonella killing by community-associated and healthcare-associated meticillin-resistant Staphylococcus aureus strains
Community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) have emerged globally and have been associated with more severe disease than healthcare-associated MRSA (HA-MRSA). The purpose of this study was to determine whether laboratory measures of virulence can distinguish dominant CA-MRSA clones from HA-MRSA clones. We compared the production of phenol-soluble modulins (PSMs) and ability to kill Galleria mellonella caterpillars for a range of CA- and HA-MRSA strains. Twenty-two HA-MRSA strains [ST22-IV (EMRSA-15), ST36-II (EMRSA-16) and ST239-III] and 26 CA-MRSA strains [ST1-IV (PVL+ USA400), ST1-IV (PVL–), ST8-IV (USA300), ST22-IV (PVL+), ST30-IV, ST59-IV and ST80-IV] were analysed. PSM production was measured using and compared using t-tests and ANOVA. A G mellonella (caterpillar) pathogenicity model was performed, and differences were compared using survival analysis and the log-rank test. There was no significant difference in overall PSM production between HA and CA strains (P=0.090), but there was significant variation between clones (P=0.003). G. mellonella caterpillar killing varied significantly by clone (P<0.001), and overall killing was greater for HA compared with CA clones (P=0.007). The increased acute virulence phenotype of CA-MRSA clones in humans is not associated with increased PSM production in vitro or increased killing in an in vivo caterpillar pathogenicity model.
- 16 December 2016
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 65 (12) , 1429-1433
Comparative analysis of phenol-soluble modulin production and Galleria mellonella killing by community-associated and healthcare-associated meticillin-resistant Staphylococcus aureus strains
Community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) have emerged globally and have been associated with more severe disease than healthcare-associated MRSA (HA-MRSA). The purpose of this study was to determine whether laboratory measures of virulence can distinguish dominant CA-MRSA clones from HA-MRSA clones. We compared the production of phenol-soluble modulins (PSMs) and ability to kill Galleria mellonella caterpillars for a range of CA- and HA-MRSA strains. Twenty-two HA-MRSA strains [ST22-IV (EMRSA-15), ST36-II (EMRSA-16) and ST239-III] and 26 CA-MRSA strains [ST1-IV (PVL+ USA400), ST1-IV (PVL–), ST8-IV (USA300), ST22-IV (PVL+), ST30-IV, ST59-IV and ST80-IV] were analysed. PSM production was measured using and compared using t-tests and ANOVA. A G mellonella (caterpillar) pathogenicity model was performed, and differences were compared using survival analysis and the log-rank test. There was no significant difference in overall PSM production between HA and CA strains (P=0.090), but there was significant variation between clones (P=0.003). G. mellonella caterpillar killing varied significantly by clone (P<0.001), and overall killing was greater for HA compared with CA clones (P=0.007). The increased acute virulence phenotype of CA-MRSA clones in humans is not associated with increased PSM production in vitro or increased killing in an in vivo caterpillar pathogenicity model.
- Open Access
- 16 December 2016
- Published by F1000 Research Ltd
- Vol. 5
Isolation and characterisation of circulating neurofilament-containing aggregates in health and disease
BACKGROUND: There are currently no accurate diagnostic or prognostic tools for ALS, resulting in delayed diagnosis and poor disease stratification. Although the aetiology of ALS is still unknown, a hallmark of this neurological condition is the presence of protein aggregates within neurons (1). In addition, ALS and other neurodegenerative diseases are associated with a compromised blood brain barrier (BBB), resulting in leakage of brain-derived proteins into plasma (2). Thus, plasma could represent a readily accessible source of diagnostic and prognostic biomarkers. We and others have shown that Neurofilaments (NFs) in cerebrospinal fluid (CSF) and plasma are a promising ALS biomarker, but suffer from high variability within and between patients. Interestingly, our data suggest that this could in part be due to epitope masking caused by protein aggregation. We propose that these circulating NF aggregates will have multiple protein components, reflecting both mechanistic and random associations. Thus, the identification of these aggregate components may provide a source of sensitive and specific biomarkers for the early diagnosis and prognostic monitoring of ALS patients. OBJECTIVES: To develop and validate a method for the isolation of circulating blood protein aggregates and to characterise the composition of these aggregates by Mass Spectrometry (MS) based Proteomics. METHODS: In order to establish the best isolation method, a Pooled Plasma sample (PP) has been created using plasma from six Healthy Controls between 51.2-62.9 years of age and with known blood level of NF heavy chain (between 7.0 and 42.9ng/ml). Two different conditions for aggregate isolation have been evaluated, Sedimentation velocity and Seprion TM ligand interaction. RESULTS: Western blot (WB) showed a detectable amount of NFs in the aggregate fractions. Tandem MS data showed the presence of 651 and 1068 proteins (Protein Grouping: True; Peptide Confidence: High; Minimal number of peptides: 1) for the sedimentation and ligand methods, respectively. 380 common proteins were found between the two methods. DISCUSSION: We showed that sedimentation is a good methodology for isolation of aggregates circulating in blood. The detection of high molecular weight bands by WB suggests the presence of aggregates containing NFs in our pellets. Also, from proteomics data it is clear that these two methods isolate cytoskeletal and other intracellular proteins, potential allowing the detection of CNS derived material. Further analysis is ongoing to evaluate the best methods for isolation and analysis. AKNOLEDGMENTS: This project is funded by an MRC-Industry CASE Studentship. Plasma samples obtained from study 09/H0703/27. REFERENCES: Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta neuropathologica. 2013;125(6):777-94. Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, et al. Impaired blood-brain/spinal cord barrier in ALS patients. Brain research. 2012;1469:114-28.
- 16 December 2016
- Published by F1000 Research Ltd
- Vol. 5
Open AccessIsolation and characterisation of circulating neurofilament-containing aggregates in health and disease
BACKGROUND: There are currently no accurate diagnostic or prognostic tools for ALS, resulting in delayed diagnosis and poor disease stratification. Although the aetiology of ALS is still unknown, a hallmark of this neurological condition is the presence of protein aggregates within neurons (1). In addition, ALS and other neurodegenerative diseases are associated with a compromised blood brain barrier (BBB), resulting in leakage of brain-derived proteins into plasma (2). Thus, plasma could represent a readily accessible source of diagnostic and prognostic biomarkers. We and others have shown that Neurofilaments (NFs) in cerebrospinal fluid (CSF) and plasma are a promising ALS biomarker, but suffer from high variability within and between patients. Interestingly, our data suggest that this could in part be due to epitope masking caused by protein aggregation. We propose that these circulating NF aggregates will have multiple protein components, reflecting both mechanistic and random associations. Thus, the identification of these aggregate components may provide a source of sensitive and specific biomarkers for the early diagnosis and prognostic monitoring of ALS patients. OBJECTIVES: To develop and validate a method for the isolation of circulating blood protein aggregates and to characterise the composition of these aggregates by Mass Spectrometry (MS) based Proteomics. METHODS: In order to establish the best isolation method, a Pooled Plasma sample (PP) has been created using plasma from six Healthy Controls between 51.2-62.9 years of age and with known blood level of NF heavy chain (between 7.0 and 42.9ng/ml). Two different conditions for aggregate isolation have been evaluated, Sedimentation velocity and Seprion TM ligand interaction. RESULTS: Western blot (WB) showed a detectable amount of NFs in the aggregate fractions. Tandem MS data showed the presence of 651 and 1068 proteins (Protein Grouping: True; Peptide Confidence: High; Minimal number of peptides: 1) for the sedimentation and ligand methods, respectively. 380 common proteins were found between the two methods. DISCUSSION: We showed that sedimentation is a good methodology for isolation of aggregates circulating in blood. The detection of high molecular weight bands by WB suggests the presence of aggregates containing NFs in our pellets. Also, from proteomics data it is clear that these two methods isolate cytoskeletal and other intracellular proteins, potential allowing the detection of CNS derived material. Further analysis is ongoing to evaluate the best methods for isolation and analysis. AKNOLEDGMENTS: This project is funded by an MRC-Industry CASE Studentship. Plasma samples obtained from study 09/H0703/27. REFERENCES: Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta neuropathologica. 2013;125(6):777-94. Garbuzova-Davis S, Hernandez-Ontiveros DG, Rodrigues MC, Haller E, Frisina-Deyo A, Mirtyl S, et al. Impaired blood-brain/spinal cord barrier in ALS patients. Brain research. 2012;1469:114-28.
- Open Access
- 4 November 2016
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 31 (2) , 153-159
Combined tissue and fluid proteomics with Tandem Mass Tags to identify low‐abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study
Rationale: Ideal biomarkers are present in readily accessible samples including plasma and cerebrospinal fluid (CSF), and are directly derived from diseased tissue, therefore likely to be of relatively low abundance. Traditional unbiased proteomic approaches for biomarker discovery have struggled to detect low‐abundance markers due to the high dynamic range of proteins, the predominance of hyper‐abundant proteins, and the use of data‐dependent acquisition mass spectrometry (MS). To overcome these limitations and improve biomarker discovery in peripheral fluids, we have developed TMTcalibrator™; a novel MS workflow combining isobarically labelled diseased tissue digests in parallel with an appropriate set of labelled body fluids to increase the chance of identifying low‐abundance, tissue‐derived biomarkers. Methods: A disease relevant cell line was labelled with TMT® in a range of concentrations generating a multi‐point calibration curve. Peripheral biofluid samples were labelled with the remaining tags and quantitative analysis was performed using an Orbitrap Fusion Tribrid mass spectrometer with a Top10 CID‐HCD MS3 synchronous precursor selection (SPS) method. SPS allowed direct analysis of non‐depleted, unfractionated CSF samples with complete profiling of six individual samples requiring only 15 hours of MS time, equivalent to 1.5 h per sample. Results: Using the TMTcalibrator™ workflow allowed the identification of several markers of microglia activation that are differentially quantified in the CSF of patients with Alzheimer's disease (AD). We report peptides from 41 proteins that have not previously been detected in the CSF, that appear to be regulated by at least 60% in AD. Conclusions: This study has demonstrated the benefits of the new TMTcalibrator™ workflow and the results suggest this is a suitable and efficient method of detecting low‐abundance peptides within biological fluids. The use of TMTcalibrator™ in further biomarker discovery studies should be considered to overcome some of the limitations commonly associated with more conventional approaches. Copyright © 2016 John Wiley & Sons, Ltd.
- 4 November 2016
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 31 (2) , 153-159
Open AccessCombined tissue and fluid proteomics with Tandem Mass Tags to identify low‐abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study
Rationale: Ideal biomarkers are present in readily accessible samples including plasma and cerebrospinal fluid (CSF), and are directly derived from diseased tissue, therefore likely to be of relatively low abundance. Traditional unbiased proteomic approaches for biomarker discovery have struggled to detect low‐abundance markers due to the high dynamic range of proteins, the predominance of hyper‐abundant proteins, and the use of data‐dependent acquisition mass spectrometry (MS). To overcome these limitations and improve biomarker discovery in peripheral fluids, we have developed TMTcalibrator™; a novel MS workflow combining isobarically labelled diseased tissue digests in parallel with an appropriate set of labelled body fluids to increase the chance of identifying low‐abundance, tissue‐derived biomarkers. Methods: A disease relevant cell line was labelled with TMT® in a range of concentrations generating a multi‐point calibration curve. Peripheral biofluid samples were labelled with the remaining tags and quantitative analysis was performed using an Orbitrap Fusion Tribrid mass spectrometer with a Top10 CID‐HCD MS3 synchronous precursor selection (SPS) method. SPS allowed direct analysis of non‐depleted, unfractionated CSF samples with complete profiling of six individual samples requiring only 15 hours of MS time, equivalent to 1.5 h per sample. Results: Using the TMTcalibrator™ workflow allowed the identification of several markers of microglia activation that are differentially quantified in the CSF of patients with Alzheimer's disease (AD). We report peptides from 41 proteins that have not previously been detected in the CSF, that appear to be regulated by at least 60% in AD. Conclusions: This study has demonstrated the benefits of the new TMTcalibrator™ workflow and the results suggest this is a suitable and efficient method of detecting low‐abundance peptides within biological fluids. The use of TMTcalibrator™ in further biomarker discovery studies should be considered to overcome some of the limitations commonly associated with more conventional approaches. Copyright © 2016 John Wiley & Sons, Ltd.
- 1 November 2016
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 55 (1) , 303-313
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
Aberrant tau phosphorylation is a hallmark in Alzheimer’s disease (AD), believed to promote formation of paired helical filaments, the main constituent of neurofibrillary tangles in the brain. While cerebrospinal fluid (CSF) levels of total tau and t
- 1 November 2016
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 55 (1) , 303-313
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
Aberrant tau phosphorylation is a hallmark in Alzheimer’s disease (AD), believed to promote formation of paired helical filaments, the main constituent of neurofibrillary tangles in the brain. While cerebrospinal fluid (CSF) levels of total tau and t
- 10 May 2016
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 52 (2) , 561-572
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
Increasingly, clinical trials for Alzheimer’s disease (AD) are being conducted earlier in the disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau and Aβ measures to quantify pathology. However, making such a pre
- 10 May 2016
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 52 (2) , 561-572
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly
Increasingly, clinical trials for Alzheimer’s disease (AD) are being conducted earlier in the disease phase and with biomarker confirmation using in vivo amyloid PET imaging or CSF tau and Aβ measures to quantify pathology. However, making such a pre